Filing Details

Accession Number:
0001209191-15-035342
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-21 17:13:21
Reporting Period:
2015-04-20
Filing Date:
2015-04-21
Accepted Time:
2015-04-21 17:13:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1240656 H Joseph Smith C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Evp, Bus Dev And Gc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-20 34,352 $9.08 48,837 No 4 M Direct
Common Stock Disposition 2015-04-20 34,352 $55.18 14,485 No 4 S Direct
Common Stock Acquisiton 2015-04-21 57,514 $19.85 71,999 No 4 M Direct
Common Stock Disposition 2015-04-21 51,308 $54.02 20,691 No 4 S Direct
Common Stock Disposition 2015-04-21 6,206 $54.98 14,485 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2015-04-20 34,352 $0.00 34,352 $9.08
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2015-04-21 57,514 $0.00 57,514 $19.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-01-01 2015-04-27 No 4 M Direct
0 2009-04-24 2015-04-24 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  2. The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
  3. 1/48th of the shares subject to the grant vest and become exercisable monthly from the grant date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
  4. 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.